CELESTONE SOLUSPAN: BETAMETHASONE SODIUM PHOSPHATE A.
BETAMETHASONE SODIUM PHOSPHATE A. Key specifications include features_provided: STERILE, primary_container_type: BOTTLE, protective_storage_feature: SUBJECT TO DAMAGE BY FREEZING, pharmaceutical_vehicle_type: ANY ACCEPTABLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 5.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-00-904-2190, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| features_provided | STERILE |
| primary_container_type | BOTTLE |
| protective_storage_feature | SUBJECT TO DAMAGE BY FREEZING |
| pharmaceutical_vehicle_type | ANY ACCEPTABLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 5.000 MILLILITERS |
| active_medicament_medicinal_strength | 3.000 MILLIGRAMS BETAMETHASONE ACETATE PER MILLILITER AND 3.000 MILLIGRAMS BETAMETHASONE SODIUM PHOSPHATE PER MILLILITER |
| part_name_assigned_by_controlling_agency | BETAMETHASONE SODIUM PHOSPHATE & ACETATE SUSP STER 3MG P/ML 5ML |
| NSN | 6505-00-904-2190 |
| PRIMARY CONTAINER CONTENT QUANTITY | 5.000 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | BOTTLE |
| PROTECTIVE STORAGE FEATURE | SUBJECT TO DAMAGE BY FREEZING |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | BETAMETHASONE SODIUM PHOSPHATE & ACETATE SUSP STER 3MG P/ML 5ML |
| PHARMACEUTICAL VEHICLE TYPE | ANY ACCEPTABLE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 3.000 MILLIGRAMS BETAMETHASONE ACETATE PER MILLILITER AND 3.000 MILLIGRAMS BETAMETHASONE SODIUM PHOSPHATE PER MILLILITER |